Genetic diversity and antibiotic resistance of clinical and environmental Vibrio cholerae suggests that many serogroups are reservoirs of resistance

Epidemiology and Infection

Volumn 132, Issue 5, 2004, Pages 985-992

  Campos, L C ^a   Zahner, V ^a   Avelar, K E S ^a   Alves, R M ^a   Pereira, D S G ^a   Vital Brazil, J M ^a   Freitas, F S ^a   Salles, C A ^a   Karaolis, D K R ^b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; ANTIBIOTIC AGENT; BACTERIAL ANTIGEN; CEFALOTIN; CEFAMANDOLE; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; FURAZOLIDONE; GENTAMICIN; NALIDIXIC ACID; OFLOXACIN; PLASMID DNA; STREPTOMYCIN; SULFONAMIDE; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BRAZIL; CLONE; CONTROLLED STUDY; ENVIRONMENT; GENETIC VARIABILITY; INTEGRON; MOLECULAR CLONING; MULTILOCUS ENZYME ELECTROPHORESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; POLYMERASE CHAIN REACTION; RESERVOIR; SOUTH AMERICA; STRAIN DIFFERENCE; VIBRIO CHOLERAE;

ANTI-INFECTIVE AGENTS; BRAZIL; CHOLERA; DISEASE RESERVOIRS; DNA PRIMERS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS; HUMANS; POLYMERASE CHAIN REACTION; VIBRIO CHOLERAE;

EID: 4744355177     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268804002705     Document Type: Article

References (37)

1. Blake PA. Historical perspectives on pandemic cholera. In: Wachsmuth IK, Blake PA, Olsvik Ø, eds. Vibrio cholerae and cholera: molecular to global perspectives. Washington, DC: American Society for Microbiology, 1994: 293-295.
2. Tauxe R, Seminario L, Tapia R, et al. The Latin American epidemic. In: Wachsmuth IK, Blake PA, Olsvik Ø, eds. Vibrio cholerae and cholera: molecular to global perspectives. Washington, DC: American Society for Microbiology, 1994: 321-344.
3. Centro Nacional de Epidemiologia. Boletim Epidemiológico, Ano 01, No 01, Fundação Nacional de Saúde, Ministério da Saúde, Brasília, DF, 2001: 1-9.
4. Centro Nacional de Epidemiologia. Evolução temporal das doenças de notificação compulsória no Brasil de 1980 a 1998. Boletim Epidemiológico, Edição Especial, Ano III, Fundação Nacional de Saúde, Ministério da Saúde, Brasília, DF, 1999: 1-48.
5. Gerolomo M, Penna MLF. Os primeiros cinco anos da sétima pandemia de cólera no Brasil. Informe Epidemiológico do SUS 1999; 8: 49-58.
6. Salles CA, Momen H. Identification of Vibrio cholerae by enzyme electrophoresis. Trans Royal Soc Trop Med Hyg 1991; 85: 544-547.
7. Cameron DN, Khambaty FM, Wachsmuth IK, Tauxe RV, Barrett TJ. Molecular characterization of Vibrio cholerae O1 strains by pulsed-field gel electrophoresis. J Clin Microbiol 1994; 32: 1685-1690.
8. Popovic T, Bopp C, Olsvik Ø, Wachsmuth K. Epidemiologic application for a standardized ribotype scheme for Vibrio cholerae O1. J Clin Microbiol 1993; 31: 2474-2482.
9. Jiang SC, Matte M, Matte G, Huq A, Colwell RR. Genetic diversity of clinical and environmental isolates of Vibrio cholerae determined by amplified fragment length polymorphism fingerprinting. Appl Environ Microbiol 2000; 66: 148-153.
10. Siddique AK, Zaman K, Baqui AH, et al. Cholera epidemics in Bangladesh: 1985-1991. J Diarrhoeal Dis Res 1992; 10: 79-86.
11. Vital Brazil JM, Alves RM, Rivera ING, Rodrigues DP, Karaolis DKR, Campos LC. Prevalence of virulence-associated genes in clinical and environmental Vibrio cholerae strains isolated in Brazil between 1991 and 1999. FEMS Microbiol Lett 2002; 215: 15-21.
12. Karaolis DKR, Lan R, Kaper JB, Reeves PR. The sixth and seventh cholera pandemics are due to independent clones separately derived from environmental, non-toxigenic, non-O1 Vibrio cholerae. J Bacteriol 1995; 177: 3191-3198.
13. Karaolis DKR, Johnson JA, Bailey CC, Boedeker EC, Kaper JB, Reeves PR. A Vibrio cholerae pathogenicity island associated with epidemic and pandemic strains. Proc Natl Acad Sci USA 1998; 95: 3134-3139.
14. Freitas FS, Momen H, Salles CA. The zymovars of Vibrio cholerae: multilocus enzyme electrophoresis of Vibrio cholerae. Mem Inst Oswaldo Cruz 2002; 97: 511-516.
15. Wachsmuth IK, Evins GM, Fields PI, et al. The molecular epidemiology of cholera in Latin America. J Infect Dis 1993; 167: 621-626.
16. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility test; approved standard, 8th edn; document M2-A8, Villanova PA, 2003.
17. Centers for Disease Control and Prevention. Laboratory methods for the diagnosis of epidemic dysentery and cholera. Atlanta: Centers for Disease Control, 1999.
18. Sambrook J, Russell DW, eds. Molecular cloning: a laboratory manual, 3rd edn. New York: Cold Spring Harbor, 2001.
19. Macrina FL, Kopecko DJ, Jones KR, Ayers DF, McCowen SK. A multiple plasmid-containing Escherichia coli strain: convenient source of size reference plasmid molecules. Plasmid 1987; 1: 417-420.
20. Threlfall EJ, Rowe B, Ferguson JL, Ward LR. Characterization of plasmids conferring resistance to gentamycin and apramycin in strains of Salmonella typhimurium phage type 204c isolated in Britain. J Hyg (Lond) 1986; 97: 419-426.
21. Dalsgaard A, Forslund A, Serichantalergs O, Sandvang D. Distribution and content of class 1 integrons in different Vibrio cholerae O-serotype strains isolated in Thailand. Antimicrob Agents Chemother 2000; 44: 1315-1321.
22. Maidhof H, Guerra B, Abbas S, Elsheikha HM, Whittam TS, Beutin L. A multiresistant clone of Shiga toxin-producing Escherichia coli O118:[16] is spread in cattle and humans over different European countries. Appl Environ Microbiol 2002; 68: 5834-5842.
23. Selander RK, Caugant DA, Ochman H, Mosser JM, Gilmour MN, Whittam TS. Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics. Appl Environ Microbiol 1986; 51: 873-884.
24. Chakraborty S, Garg P, Ramamurthy T, et al. Comparison of antibiogram, virulence genes, ribotypes and DNA fingerprints of Vibrio cholerae of matching sero-groups isolated from hospitalised diarrhoea cases and from the environment during 1997-1998 in Calcutta, India. J Med Microbiol 2001; 50: 879-888.
25. Dalsgaard A, Forslund A, Bodhidatta L, et al. A high proportion of Vibrio cholerae strains isolated from children with diarrhoea in Bangkok, Thailand are multiple antibiotic resistant and belong to heterogenous non-O1, non-O139 O-serotypes. Epidemiol Infect 1999; 122: 217-226.
26. Garg P, Chakraborty S, Basu I, et al. Expanding multiple antibiotic resistance among clinical strains of Vibrio cholerae isolated from 1992-7 in Calcutta, India. Epidemiol Infect 2000; 124: 393-399.
27. Hofer E, Quintaes BR, Reis EMF, et al. Emergence of multiple drug resistance in Vibrio cholerae isolated from patients with gastroenteritis in Ceará, Brazil [in Portuguese]. Rev Soc Bras Med Trop 1999; 32: 151-156.
28. Radu S, Ho YK, Lihan S, et al. Molecular characterization of Vibrio cholerae O1 and non-O1 from human and environmental sources in Malaysia. Epidemiol Infect 1999; 123: 225-232.
29. Mahlu FS, Mmari PW, Ijumba J. Rapid emergence of El Tor Vibrio cholerae resistant to antimicrobial agents during the first six months of fourth cholera epidemic in Tanzania. Lancet 1979; i: 345-347.
30. Weber JT, Mintz ED, Canizares R, et al. Epidemic cholera in Ecuador: multidrug-resistance and transmission by water and seafood. Epidemiol Infect 1992; 112: 1-11.
31. Doganci L, Gun H, Baysallar M, Albay A, Cinar E, Haznedaroglu T. Short-term quinolones for successful eradication of multiply resistant Vibrio cholerae in adult patients. Scand J Infect Dis 1995; 27: 425-426.
32. Gottuzo E, Seas C, Echevarria J, Carrillo C, Mostorino R, Ruiz R. Ciprofloxacin for the treatment of cholera: a randomized, double-blind, controlled clinical trial of a single daily dose in Peruvian adults. Clin Infect Dis 1995; 20: 1485-1490.
33. Amita, Chowdhury SR, Thungapathra M, Ramamurthy T, Nair GB, Ghosh A. Class I integrons and SXT elements in El Tor strains isolated before and after 1992 Vibrio cholerae O139 outbreak, Calcutta, India. Emerg Infect Dis 2003; 9: 500-502.
34. Hochhut B, Waldor MK. Site-specific integration of the conjugal Vibrio cholerae SXT element into prfc. Mol Microbiol 1999; 32: 99-110.
35. Rivera IG, Chowdhury MAR, Huq A, Jacobs D, Martins MT, Colwell RR. Enterobacterial pepetitive intergenic consensus sequences and the PCR to generate fingerprints of genomic DNAs from Vibrio cholerae O1, O139, and non-O1 strains. Appl Environ Microbiol 1995; 61: 2898-2904.
36. Singh DV, Matte MH, Matte GR, et al. Molecular analysis of Vibrio cholerae O1, O139, non-O1, and non-O139 strains: clonal relationships between clinical and environmental isolates. Appl Environ Microbiol 2001; 67: 910-921.
37. Albert MJ, Bhuiyan NA, Talukder KA, et al. Phenotypic and genotypic changes in Vibrio cholerae O139 Bengal. J Clin Microbiol 1997; 35: 2588-2592.